Loading chat...

FL H1481

Bill

Status

Introduced

3/6/2023

Primary Sponsor

Health & Human Services Committee

Click for details

Origin

House of Representatives

2023 Regular Session

AI Summary

  • Screening providers must notify primary care physicians and the Department of Health when newborns or infants are detected carrying sickle cell hemoglobin variants for inclusion in a registry.

  • Primary care physicians must provide parents and guardians with information about the availability and benefits of genetic counseling.

  • Department of Health shall contract with a community-based sickle cell disease center to establish and maintain a registry tracking sickle cell disease outcome measures, with parents/guardians able to request removal.

  • The Agency for Health Care Administration must conduct a biennial review of sickle cell disease medications, treatments, and services for Medicaid recipients and submit reports to the Governor, Legislature, and specified entities starting November 1, 2024.

  • Appropriates $250,000 to the Agency for Health Care Administration and $1,082,159 to the Department of Health for fiscal year 2023-2024, along with five full-time positions, effective July 1, 2023.

Legislative Description

Sickle Cell Disease Medications, Treatment, and Screening

Last Action

Laid on Table; companion bill(s) passed, see CS/CS/SB 1352 (Ch. 2023-258)

5/2/2023

Committee Referrals

Health And Human Services4/13/2023
Health Care Appropriations Subcommittee3/27/2023
Healthcare Regulation Subcommittee3/9/2023

Full Bill Text

No bill text available